Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

Illumina (NASDAQ:ILMN) will release fourth quarter and full year 2025 financial results after market close on Thursday, February 5, 2026.

Rhea-AI Summary

Illumina (NASDAQ:ILMN) will release fourth quarter and full year 2025 financial results after market close on Thursday, February 5, 2026.

Management will host a conference call at 1:30 PM PT / 4:30 PM ET on the same day. Investors can access a live webcast via the company's Investor Info website or the provided link. A replay will be posted on the website and remain available for at least 30 days.

Argus Jan 13 session

+0.99% close to close Open Argus

Details

News Market Reaction – ILMN

On Jan 13, the first trading day after this news, ILMN closed 0.99% above the previous close.

Data tracked by StockTitan Argus for the Jan 13 session.

Market Context

This announcement sets the timetable for Illumina’s fourth-quarter and full-year 2025 results and re...

Analysis

This announcement sets the timetable for Illumina’s fourth-quarter and full-year 2025 results and related conference call. It follows recent product launches, collaborations, and scientific publications highlighted in prior months. Investors can use this scheduled date to frame expectations against the company’s disclosed debt offerings and strategic initiatives. Key items to watch at the call include financial performance, updates on collaborations, and any commentary on previously announced research and product platforms.

Key Figures

Earnings date: February 5, 2026 Conference call time: 1:30 pm Pacific Time Replay availability: At least 30 days

Earnings date

February 5, 2026

Q4 and full-year 2025 results release after market close

Conference call time

1:30 pm Pacific Time

Earnings call start time on February 5, 2026

Replay availability

At least 30 days

Archived earnings call replay on Illumina’s website

Historical Context

5 past events · Latest: Jan 06

5 events

1. Jan 06

   Product software launch

   24h Move

   +4.1%

   Launch of Illumina Connected Multiomics cloud-based analysis platform.

2. Dec 16

   Investor conference

   24h Move

   -1.5%

   Announcement of J.P. Morgan Healthcare Conference presentation webcast.

3. Dec 11

   Collaboration deal

   24h Move

   +1.1%

   Collaboration and strategic investment in MyOme to support MPH Trial.

4. Dec 11

   Correction notice

   24h Move

   +1.1%

   Correction to prior MyOme collaboration and MPH trial announcement.

5. Nov 12

   Scientific study

   24h Move

   -0.5%

   Nature study showing WGS captures ~90% of genetic signal in diseases.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Jan. 12, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the fourth quarter and full year 2025 following the close of market on Thursday, February 5, 2026.

On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. 

Conference Call Details

The conference call will begin at 1:30 pm Pacific Time (4:30 pm Eastern Time) on Thursday, February 5, 2026. Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link - https://illumina-earnings-call-q4-2025.open-exchange.net. To ensure timely connection, please join at least ten minutes before the scheduled start of the call.

A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.

Investors:
Conor McNamara
+1.858.291.6421
ir@illumina.com 

Media:
Christine Douglass
pr@illumina.com 

View original content:https://www.prnewswire.com/news-releases/illumina-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-thursday-february-5-2026-302658954.html

SOURCE Illumina, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Illumina (ILMN) report Q4 and full year 2025 results?

Illumina will release Q4 and full year 2025 results after market close on February 5, 2026.

What time is the Illumina (ILMN) earnings call on February 5, 2026?

The conference call is scheduled for 1:30 PM Pacific / 4:30 PM Eastern on February 5, 2026.

Who will present Illumina's (ILMN) February 5, 2026 earnings call?

Jacob Thaysen, PhD (CEO) and Ankur Dhingra (CFO) will host the conference call.

How can investors access the Illumina (ILMN) live webcast for the Q4 2025 results?

Investors can join the live webcast via the Investor Info section of Illumina's website or the provided webcast link; join at least 10 minutes early.

Will a replay of Illumina's (ILMN) February 5, 2026 earnings call be available?

Yes. A replay will be posted on Illumina's website after the event and will be available for at least 30 days.